U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2844128441Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan AfricaRecruitingNo Results AvailableHIV|Reproductive Health|Disabilityhttps://ClinicalTrials.gov/show/NCT02192658
2844228442The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled StudyRecruitingNo Results AvailableAllergic RhinitisDrug: Sanfujiu|Drug: placebohttps://ClinicalTrials.gov/show/NCT02192645
2844328443Dermatologists' Educational Demonstration for Epiduo ApplicationCompletedNo Results AvailableFacial Acne|Local Adverse EffectsDrug: Epiduo once daily with detailed instruction for how to apply it|Drug: Epiduo- once daily, simple instruction for application|Drug: BPO once dailyhttps://ClinicalTrials.gov/show/NCT02192632
2844428444National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML IntergroupRecruitingNo Results AvailableNewly-diagnosed APL (de Novo or Therapy-related)|Relapsed APLOther: observationalhttps://ClinicalTrials.gov/show/NCT02192619
2844528445Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?Enrolling by invitationNo Results AvailableUterine Fibroids|Abnormal Uterine Bleeding|Pelvic Pain|AdenomyosisDevice: Storz 3D Laparoscopy System|Device: 2D Laparoscopyhttps://ClinicalTrials.gov/show/NCT02192606
2844628446Computerized Cognitive-Behavioral Therapy for Auditory HallucinationsCompletedNo Results AvailableSchizophrenia, Schizoaffective DisorderBehavioral: Computer CBThttps://ClinicalTrials.gov/show/NCT02192593
2844728447Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in ChildrenRecruitingNo Results AvailableAcute Pyelonephritis(APN)Drug: Omega-3https://ClinicalTrials.gov/show/NCT02192580
2844828448Open Label Study of DS-5573aRecruitingNo Results AvailableAdvanced Solid Malignant TumorsDrug: DS-5573ahttps://ClinicalTrials.gov/show/NCT02192567
2844928449Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or PlaceboEnrolling by invitationNo Results AvailableAgitation Associated With Alzheimer's Disease|Alzheimer's Type|Mental Disorder|Nervous System Diseaseshttps://ClinicalTrials.gov/show/NCT02192554
2845028450Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and SarcomasRecruitingNo Results AvailableNeoplasmsDrug: Ziv-Aflibercept|Drug: Ganetespibhttps://ClinicalTrials.gov/show/NCT02192541
2845128451Vitamin D and Outcome in Cardiac SurgeryCompletedNo Results AvailableCardiovascular Diseasehttps://ClinicalTrials.gov/show/NCT02192528
2845228452A Study of APD356 (Lorcaserin) in Healthy Japanese Adult SubjectsActive, not recruitingNo Results AvailableHealthy SubjectsDrug: APD356 10 mg|Drug: APD356 XR-20 mg|Drug: APD356 10 mg matching Placebo|Drug: APD356 XR-20 mg matching Placebo|Drug: APD356 20 mg|Drug: APD356 20 mg matching Placebo|Drug: APD356 XR-20 mg (orange tablet)|Drug: APD356 XR-20mg (orange tablet, fed state)https://ClinicalTrials.gov/show/NCT02192515
2845328453Use of 6% Hydroxyethylstarch (130/0.4) in Cardiac Surgical PatientsRecruitingNo Results AvailablePostoperative Kidney InjuryDrug: human albumin 5%|Drug: HES 130/0.4 (Voluven)https://ClinicalTrials.gov/show/NCT02192502
2845428454A Phase 2 Study With CC-220 in Skin SarcoidosisWithdrawnNo Results AvailableSarcoidosisDrug: CC-220 0.3 mg Daily|Drug: CC-220 0.6mg Daily|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02192489
2845528455Efficacy of CTPT Method in the Treatment of Post Stroke Shoulder SubluxationCompletedNo Results AvailableSubluxation of Inferior ShoulderOther: conventional neuro rehabilitation programme|Other: California tri-pull taping (CTPT)https://ClinicalTrials.gov/show/NCT02192476
2845628456Relative Bioavailability of Different Oral Viramune Extended Release Formulations Compared to Viramune® Oral Suspension in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: NVP ER 300 mg (KCR 20%) Medium Release|Drug: NVP ER 300 mg (KCR 25%) Medium Release|Drug: NVP ER 300 mg (KCR 30%) Slow Release|Drug: NVP ER 400 mg (KCR 25%) Medium Release|Drug: NVP ER 300 mg (KCR 40%) Slow Release|Drug: NVP ER 300 mg (ECR 20%) Fast Release|Drug: NVP ER 400 mg (KCR 20%) Medium Release|Drug: NVP ER 400 mg (KCR 30%) Slow Release|Drug: NVP ER 400 mg (KCR 40%) Slow Release|Drug: NVP ER 400 mg (ECR 20%) Fast Release|Drug: Nevirapine immediate release (IR) 200 mghttps://ClinicalTrials.gov/show/NCT02192463
2845728457Insulin Degludec and Symptomatic Nocturnal HypoglycaemiaRecruitingNo Results AvailableType 1 Diabetes Mellitus|Nocturnal Hypoglycemia|Recurrent Severe HypoglycaemiaDrug: Insulin aspart/glargine|Drug: Insulin aspart/degludechttps://ClinicalTrials.gov/show/NCT02192450
2845828458Dietary Methionine and Cysteine Restriction in Healthy AdultsRecruitingNo Results AvailableHealthyOther: Sulfur amino acid restricted diethttps://ClinicalTrials.gov/show/NCT02192437
2845928459Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)RecruitingNo Results AvailableType 2 DiabetesDrug: Metformin alone|Drug: Metformin + Intermittent Insulin Therapyhttps://ClinicalTrials.gov/show/NCT02192424
2846028460Efficacy of Variable Lidocaine Concentrations in Tumescent Anesthesia for Pain Control During and After Endovenous Laser Procedure; Non-inferiority TrialNot yet recruitingNo Results AvailablePain During and After Endovenous Laser Obliteration of Large Saphenous Vein Based on Lidocaine Tumescent ConcentrationDrug: Lidocainehttps://ClinicalTrials.gov/show/NCT02192411
2846128461Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)RecruitingNo Results AvailableChronic PainDrug: Guanfacine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02192398
2846228462Metabolic Syndrome and Contrast Induced NephropathyCompletedNo Results AvailableContrast Induced Nephropathy|Metabolic Syndromehttps://ClinicalTrials.gov/show/NCT02192372
2846328463Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasNot yet recruitingNo Results AvailableAdult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain TumorBiological: carboxylesterase-expressing allogeneic neural stem cells|Drug: irinotecan hydrochloride|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT02192359
2846428464α-TEA in Advanced CancerRecruitingNo Results AvailableMetastatic Carcinoma|Metastatic Sarcoma|Metastatic LymphomaDrug: 2.4 mg/kg α-TEA|Drug: 4.8 mg/kg α-TEA|Drug: 8.0 mg/kg α-TEA|Drug: 9.6 mg/kg α-TEA|Drug: 12 mg/kg α-TEA|Drug: 16.8 mg/kg α-TEA|Drug: 19.2 mg/kg α-TEA|Drug: 22.3 mg/kg α-TEA|Drug: 26.8 mg/kg α-TEAhttps://ClinicalTrials.gov/show/NCT02192346
2846528465Survivorship Care in Reducing Symptoms in Young Adult Cancer SurvivorsRecruitingNo Results AvailableBreast Carcinoma|Cancer Survivor|Depression|Fatigue|Leukemia|Lymphoma|Malignant Bone Neoplasm|Malignant Digestive System Neoplasm|Malignant Female Reproductive System Neoplasm|Malignant Male Reproductive System Neoplasm|Pain|Sleep Disorder|Soft Tissue SarProcedure: Management of Therapy Complications|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Behavioral: Telephone-Based Interventionhttps://ClinicalTrials.gov/show/NCT02192333
2846628466The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation DisordersNot yet recruitingNo Results AvailableChronic Subdural HematomaDrug: Atorvastatin|Drug: Atorvastatin and Dexamethasonehttps://ClinicalTrials.gov/show/NCT02192320
2846728467Effectiveness of Two Water-Based Potassium Oxalate DesensitizersCompletedNo Results AvailableDentin SensitivityDevice: Potassium oxalatehttps://ClinicalTrials.gov/show/NCT02192307
2846828468Absolute Bioavailability Of BosutinibCompletedNo Results AvailableHealthyDrug: Oral Bosutinib|Drug: Intravenous infusion of bosutinibhttps://ClinicalTrials.gov/show/NCT02192294
2846928469Randomized Experiment of PlayworksCompletedNo Results AvailableFocus on Physical Activity, Recess, and PlayOther: Playworkshttps://ClinicalTrials.gov/show/NCT02192281
2847028470Assesment of the Effectiveness of High Frequency Oral Oscillation and Mask of PEP in Children With PneumoniaNot yet recruitingNo Results AvailablePneumoniaOther: PEP|Other: HFOO|Other: Assisted Coughinghttps://ClinicalTrials.gov/show/NCT02192268

* Görseller ve İçerik tekif hakkına sahip olabilir